US Genomics, Northrop Grumman to Develop, Sell Pathogen-Detection Tool for US Gov't | GenomeWeb
NEW YORK (GenomeWeb News) — US Genomics today said it will work with aerospace and defense giant Northrop Grumman to develop and market US Genomics’ biodetection technology for the Department of Homeland Security.
 
US Genomics has already received around $23 million in funding from the Homeland Security to develop a prototype of the instrument, which uses the company’s single molecule-detection technology to find “a wide range of pathogens and toxins.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.